Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04170556
Title Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING) (GOING)
Acronym GOING
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Fundacion Clinic per a la Recerca Biomedica
Age Groups: adult | senior
Covered Countries ESP

No variant requirements are available.